Latest news with #ApolloHospitalsEnterpriseLtd
Business Upturn
38 minutes ago
- Business
- Business Upturn
Apollo Hospitals shares rallies 5% as Q1 net profit jumps 42% YoY
By Aditya Bhagchandani Published on August 13, 2025, 09:28 IST Shares of Apollo Hospitals Enterprise Ltd surged over 5% to ₹7,623.50 in early trade on Wednesday, August 13, after the company reported a robust 42% year-on-year rise in consolidated net profit to ₹433 crore for Q1 FY26. The growth was powered by strong performances across its core healthcare services, diagnostics, and digital health segments. Revenue for the quarter grew 15% YoY to ₹5,842 crore, while EBITDA rose 26% to ₹852 crore, aided by margin expansion and operational efficiencies. Chairman Dr. Prathap C Reddy credited the performance to Apollo's integrated care model and strategic investments in digital platforms and infrastructure, highlighting contributions from its three growth engines—Healthcare Services, Retail Health & Diagnostics, and Digital & Pharma Distribution. The hospital segment's revenue rose 11% YoY, driven by a 3% increase in inpatient volumes and an 11% rise in ARPP, though occupancy dipped to 65% (down 300 bps). HealthCo revenues climbed 19%, with margins improving by 41 bps and the segment turning PAT positive. Looking ahead, Apollo plans to add over 4,300 beds in the next five years with a ₹7,600 crore capex, along with launches like Apollo Zen (AI-powered preventive health) and OraLife (early oral cancer detection). Brokerage sentiment remained mixed—Nomura maintained a neutral rating with a ₹6,856 target, while Citi reiterated a buy with an ₹8,260 target, citing strong Q1 performance and broad-based margin gains. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Mint
12 hours ago
- Business
- Mint
Apollo Hospitals eyes medical tourism boost, capacity growth in FY26
Apollo Hospitals Enterprise Ltd (Ahel) is stepping up its medical tourism strategy, aiming to diversify its overseas patient base beyond Bangladesh, where inflows have slowed due to an ongoing economic crisis. The company's Q1FY26 results, announced on Tuesday, showed a 42% year-on-year rise in consolidated net profit to ₹ 433 crore, up from ₹ 305 crore a year earlier. Revenue from operations climbed 15% to ₹ 5,842 crore, while earnings before interest, tax, depreciation and amortization (Ebitda) rose 26% to ₹ 852 crore. The main healthcare services division delivered an 11% revenue increase to ₹ 2,935 crore, supported by high-end surgeries and growth in speciality areas such as cardiac, oncology, neurology, gastroenterology and orthopaedics. However, a 1.5% revenue hit came from reduced medical tourism from Bangladesh, which has been declining since Q3FY25. The healthcare player is looking at attracting more patients from other markets now. 'We are doing a lot to see how we can more actively engage in some of these markets,' Madhu Sasidhar, president and chief executive officer of the hospitals division, told Mint. Apollo is eyeing a larger chunk in the African-Middle East cluster, where they have already substantially increased revenues, Sasidhar said. The hospital chain is also looking at markets in the eastern corridor like Myanmar and Cambodia, Southeast Asia, and the CIS countries as well. 'Over the next few months, you will start to see some of that come to fruition,' Sasidhar added. The hospital chain is also looking at operationalizing six new hospitals, with a total of over 1,500 new beds this year. 'There is a significant capacity that will get augmented in the next one year,' chief financial officer Krishnan Akhileswaran said. The group reiterated plans to add more than 4,300 beds over the next five years and reported network occupancy at 65% versus 68% a year earlier. The company's digital pharmacy business Apollo 24/7 is on track to break even by Q4FY26, Akhileswaran said. During the first quarter of FY26, Ahel announced the demerger of its omnichannel pharmacy and digital health business into a new entity, Apollo Healthtech, which will be listed in the next 12-18 months. 'This is the appropriate time because if you look at it, by the time we demerge, it will be Q4FY27…by that time, we should be doing reasonably good margins. And with this growth, we hope that by Q4FY27, this would be a ₹ 25,000 crore run rate company, which is a sizable number for someone like us to be able to list that company,' he said. The overall digital health and omnichannel pharmacy distribution business reported a 19% YoY growth in revenues to ₹ 2,472 crore. Ebitda stood at ₹ 94 crore against ₹ 23 crore in Q1FY25, with margins at 3.8%. Net profit stood at ₹ 57 crore during the fiscal. Apollo Hospitals' shares ended 0.1% lower at ₹ 7,253 on the National Stock Exchange ahead of the results.
News18
13 hours ago
- Business
- News18
Apollo Hospitals posts 42 pc jump in profit to Rs 433 cr in Q1
New Delhi, Aug 12 (PTI) Apollo Hospitals Enterprise Ltd on Tuesday reported a 42 per cent jump in profit after tax to Rs 433 crore in the June quarter. The healthcare services provider had reported a PAT of Rs 305 crore in the year-ago period, according to a company release. Revenues rose 15 per cent to Rs 5,842 crore in the first quarter of the current fiscal year from Rs 5,086 crore in Q1 FY25, it said. Healthcare services revenue rose 11 per cent to Rs 2,935 crore in the first quarter of FY26 against Rs 2,637 crore in Q1 FY25, the statement said. Apollo Health and Lifestyle revenue rose 19 per cent to Rs 435 crore from Rs 366 crore in the year-ago period. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Mint
07-07-2025
- Business
- Mint
Stock market today: 59 stocks hit 52-week lows, 156 stocks at 52-week high as Nifty 50, Sensex end flat
Stock market today: On Monday, 156 stocks hit their 52-week high, including Apollo Hospitals Enterprise Ltd, EID Parry India Ltd, Fortis Healthcare Ltd, Glenmark Pharmaceuticals Ltd, Kama Holdings Ltd, Laurus Labs Ltd, L&T Finance Ltd, Muthoot Finance Ltd, Navin Fluorine International Ltd, and The Ramco Cements Ltd. In contrast, 59 stocks touched 52-week lows, with notable mentions like Jindal Worldwide Ltd, Protean eGov Technologies Ltd, R K Swamy Ltd, Dreamfolks Services Ltd, V R Films & Studios Ltd, and Alacrity Securities Ltd. The Indian stock market ended today on a slight positive note despite facing early fluctuations and global uncertainties. The Nifty 50 closed near the 25,461 mark, demonstrating strength after starting the day a bit lower due to worries about the US-India trade agreement and regulatory actions, such as SEBI's temporary ban on the US quantitative firm Jane Street. The Sensex stayed relatively stable, indicating a careful attitude among investors. According to Vaibhav Vidwani, a Research Analyst at Bonanza, the market's positive closing was mainly fueled by ongoing buying interest from domestic institutional investors, which helped mitigate the impact of global trade tensions and profit-taking at elevated levels. Key sectors including FMCG, oil & gas, and real estate experienced selective buying, enhancing the overall stability of the market. Vidwani said that looking forward, market expectations appear cautiously optimistic. The short-term trend is likely to hinge on the clarity surrounding US-India trade discussions and domestic corporate earnings for Q1 FY26. Although global macro factors continue to create volatility, consistent domestic institutional support and strong sector performance may act as a cushion for the markets, facilitating a gradual recovery and consolidation in the weeks ahead.
Mint
30-05-2025
- Business
- Mint
Apollo Hospitals to deepen presence in Bengaluru, Hyderabad
Apollo Hospitals Enterprise Ltd is increasing its penetration in Bengaluru and Hyderabad through a mix of greenfield and brownfield projects, as it embarks on a large-scale expansion plan in FY26. The hospital chain has approved a brownfield expansion of 160 beds across Jubilee Hills and Secunderabad facilities in Hyderabad, as well as acquired 2.53-acre land in Sarjapur, Bengaluru for a 500-bed greenfield hospital. These are expected to be operational in 3-4 years. It has also acquired an existing 200-bed hospital in Sarjapur, which will be operational in the next two quarters, the company said. This is in addition to the chain's planned expansion in Gurugram, Hyderabad, Kolkata and Pune, which it is commencing in FY26. Also read: IHH Healthcare arm increases damages sought from Daiichi Sankyo to ₹11,800 crore over Fortis stake dispute 'Over the next one year, we will be having quite a bit of expansions coming up," chief financial officer Krishnan Akhileswaran told Mint. The chain will be adding over 4,300 beds over three to four years beginning FY26, with a total capital outlay of over ₹8,000 crore. In the fourth quarter ended March, the company's consolidated revenues rose 13% year-on-year to ₹5,592 crore. Consolidated ebitda increased 20% over a year earlier to ₹770 crore, while profit after tax (PAT) rose 54% to ₹390 crore. For FY25, Apollo's consolidated revenues rose 14% on-year to ₹21,794 crore, while ebitda grew 26% to ₹3,022 crore. PAT increased 61% to ₹1,446 crore. Also read: Zydus bets big on vaccines and medtech Hospitals business grows The company's hospitals business grew 10% year-on-year in Q4 to ₹2,822 crore, while ebitda grew 16% to ₹686.3 crore. The business reported an ebitda margin of 24.3%. 'All of this is clearly representative of the operating leverage that we have from the same facilities that we are operating out of. No new facilities added as yet," Krishnan said. The growth from the company's bed additions starting this year will be significantly seen in FY27, he said. The company saw a dip in volumes due to the loss of patients from Bangladesh. However, the current base is the lowest it can get to, Krishan said. Also read: Access to obesity management not available to most Indian patients: World Heart Federation report The company expects Apollo 24/7 to be profitable by the end of FY26. It is focusing on 20% growth for Apollo Healthco, its digital healthcare and omnichannel pharmacy arm in FY26. 'The focus [for Apollo Healthco] is more on revenue and profitability," Krishnan said.
